These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation]. MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443 [No Abstract] [Full Text] [Related]
26. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. Kane S; Ford J; Cohen R; Wagner C J Clin Gastroenterol; 2009 Aug; 43(7):613-6. PubMed ID: 19142167 [TBL] [Abstract][Full Text] [Related]
27. Drug insight: aminosalicylates for the treatment of IBD. Nielsen OH; Munck LK Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853 [TBL] [Abstract][Full Text] [Related]
28. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium. Moffatt DC; Bernstein CN Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811 [TBL] [Abstract][Full Text] [Related]
29. Crohn's disease as a risk factor for the outcome of pregnancy. Morales M; Berney T; Jenny A; Morel P; Extermann P Hepatogastroenterology; 2000; 47(36):1595-8. PubMed ID: 11149010 [TBL] [Abstract][Full Text] [Related]
30. Crohn's disease and acute leukocytoclastic vasculitis of skin. Zlatanic J; Fleisher M; Sasson M; Kim P; Korelitz BI Am J Gastroenterol; 1996 Nov; 91(11):2410-3. PubMed ID: 8931427 [TBL] [Abstract][Full Text] [Related]
31. Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II. Mottet C; Vader JP; Felley C; Froehlich F; Gonvers JJ; Juillerat P; Stockbrügger R; Angelucci E; Seibold F; Michetti P; Pittet V; J Crohns Colitis; 2009 Dec; 3(4):257-63. PubMed ID: 21172284 [TBL] [Abstract][Full Text] [Related]
32. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited? Charpignon C; Beau P Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615 [TBL] [Abstract][Full Text] [Related]
33. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease]. Netzer P Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032 [TBL] [Abstract][Full Text] [Related]
34. Review article: can post-operative recurrence in Crohn's disease be prevented? Lémann M Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():22-8. PubMed ID: 16961740 [TBL] [Abstract][Full Text] [Related]
35. Inflammatory bowel disease and pregnancy: report of two cases treated with infliximab and a review of the literature. Correia LM; Bonilha DQ; Ramos JD; Ambrogini O; Miszputen SJ Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1260-4. PubMed ID: 20671559 [TBL] [Abstract][Full Text] [Related]
36. Therapy of mild to moderate luminal Crohn's disease. Michetti P; Juillerat P; Mottet C; Gonvers JJ; Burnand B; Vader JP; Froehlich F; Felley C Digestion; 2005; 71(1):13-8. PubMed ID: 15711043 [TBL] [Abstract][Full Text] [Related]
38. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine]. Glintborg B Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226 [TBL] [Abstract][Full Text] [Related]